ETHYOL 375mg lyophilized infusion solution medication leaflet

V03AF05 • amifostine • Various | All other therapeutic products | Detoxifying agents for antineoplastic treatment

Amifostine is a cytoprotective medication used to reduce the toxicity of certain cancer treatments, such as chemotherapy and radiotherapy. It protects healthy cells from the harmful effects of these therapies, reducing the risk of complications such as xerostomia (dry mouth) or kidney damage.

Amifostine is administered intravenously, usually before the start of cancer treatment, under the supervision of a specialist doctor. The dosage and administration schedule are adjusted based on the type of treatment and the patient's overall condition.

Common side effects include nausea, vomiting, hypotension, and allergic reactions. In rare cases, severe reactions such as anaphylactic shock may occur.

Patients receiving amifostine should be closely monitored during administration, and the medication is contraindicated in individuals with known allergies to the active substance. Amifostine is a valuable option for protecting healthy tissues during cancer treatments, contributing to improved quality of life for patients.